Company news

Natera, Inc. news in 2025

Natera, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD

March 3, 2025

Natera Reports Fourth Quarter and Full Year 2024 Financial Results

February 26, 2025

Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer

February 24, 2025

Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025

February 17, 2025

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma

February 9, 2025

Natera Announces National Commercial Coverage for its Fetal RhD NIPT

February 2, 2025

Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer

January 24, 2025

Natera to Present New Data at the 2025 ASCO GI Symposium

January 20, 2025

Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year

January 16, 2025

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection

January 14, 2025

Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024

January 11, 2025

Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 6, 2025

← Newer news releases

Calls in 2025

Decks in 2025